Company Filing History:
Years Active: 2025
Title: Julia Greissl: Innovator in Lyme Disease Research
Introduction
Julia Greissl is a prominent inventor based in Redmond, WA, who has made significant contributions to the field of Lyme disease research. Her innovative work focuses on T cell receptor-related methods that can enhance the understanding and treatment of Lyme disease.
Latest Patents
Julia holds a patent for "Lyme disease-associated T cell receptor-related methods." This patent provides methods for assessing T cell receptor β chain complementary determining region 3 (TCRβ CDR3) sequences. The methods involve evaluating TCRβ CDR3 sequences from samples obtained from subjects who have or are suspected of having a tick bite. This assessment can identify the presence or absence of specific TCRβ CDR3 sequences, even in subjects who are seronegative for Lyme disease or exhibit non-specific symptoms consistent with the disease. Additionally, the patent outlines methods for administering Lyme disease therapy to subjects identified as having T cells that express a TCRβ CDR3 sequence.
Career Highlights
Julia Greissl is associated with Adaptive Biotechnologies Corporation, where she continues to advance her research in immunology and disease treatment. Her work is pivotal in developing new diagnostic and therapeutic strategies for Lyme disease.
Collaborations
Julia collaborates with notable colleagues, including Harlan Saul Robins and Thomas M Snyder, who contribute to her research efforts and the broader goals of Adaptive Biotechnologies Corporation.
Conclusion
Julia Greissl's innovative contributions to Lyme disease research exemplify the impact of scientific inquiry on public health. Her patent and ongoing work at Adaptive Biotechnologies Corporation highlight her commitment to advancing medical science and improving patient outcomes.